GSK’s Cervical Cancer Vaccine Induces Antibodies To Target Cervical Cancer Where It Starts

Two years after the first of three doses, antibodies against the two most common cervical cancer-causing virus types, induced by a vaccine, have been found where they are needed, in the cervix, according to new data presented at the International Papillomavirus Conference (IPC) in Beijing. [click link for full article]

More: continued here

Filed under: Cervical Cancer on November 7th, 2007